1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA IL18BP CTRPv2 pan-cancer AAC -0.084 0.03
mRNA PPIG CTRPv2 pan-cancer AAC 0.085 0.03
mRNA SASH3 CTRPv2 pan-cancer AAC -0.1 0.03
mRNA FAM168A CTRPv2 pan-cancer AAC -0.085 0.03
mRNA RP11-293I14.2 CTRPv2 pan-cancer AAC -0.081 0.03
mRNA COQ3 CTRPv2 pan-cancer AAC 0.082 0.03
mRNA CD93 CTRPv2 pan-cancer AAC 0.082 0.03
mRNA DCAF5 CTRPv2 pan-cancer AAC -0.085 0.03
mRNA UBXN8 CTRPv2 pan-cancer AAC 0.086 0.03
mRNA BICD1 CTRPv2 pan-cancer AAC -0.083 0.03
Download CSV